Naldemedine versus placebo for opioid-induced constipation (COMPOSE-1 and COMPOSE-2): two multicentre, phase 3, double-blind, randomised, parallel-group trials

The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)

Timothy Bell, Sunil Panchal, Christine Miaskowski et al. · Pain Medicine · 2008 · 504 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain

William D. Chey, Lynn R. Webster, Mark Sostek et al. · New England Journal of Medicine · 2014 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Patients With Chronic, Nonmalignant Pain: A Randomized Controlled Study

Edward Michna, E. Richard Blonsky, Seth L. Schulman et al. · Journal of Pain · 2011 · 153 citations

Nursing, Pharmacology, Pharmacotherapy +16

Randomised clinical trial: the long‐term safety and tolerability of naloxegol in patients with pain and opioid‐induced constipation

Lynn R. Webster, William D. Chey, Jan Tack et al. · Alimentary Pharmacology & Therapeutics · 2014 · 116 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Opioid-Induced Constipation Among Patients with Chronic Noncancer Pain in the United States, Canada, Germany, and the United Kingdom: Laxative Use, Response, and Symptom Burden Over Time

Karin S. Coyne, Mary Kay Margolis, Karen Yeomans et al. · Pain Medicine · 2015 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17